Kuehne+Nagel opens airside facilities in Brussels & Johannesburg for global distribution of vaccines

Kuehne+Nagel open airside pharma and healthcare hubs in Brussels, Belgium and Johannesburg, South Africa. With the opening of airside facilities, the company has added two strategic elements to its global GxP-certified network of temperature-controlled facilities for the distribution of vaccines and other pharma & healthcare products. As many of the temperature-sensitive products have very low to no stability outside of their stated temperature ranges, direct tarmac access at Kuehne+Nagel airside facilities even further minimises the risk of temperature excursions and ensures product integrity during the logistics journey. The new premises have dedicated areas for all ranges of temperature-sensitive products: <-20°C, +2° to +8°C and +15° to +25°C. In addition, these facilities have the ability to change or add dry ice as required for deep frozen shipment where temperatures need to be maintained below -60°C.